Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years.
Gholami F, Hamidi Farahani R, Karimi Rahjerdi A, Ahi M, Sheidaei A, Gohari K, Rahimi Z, Ansarifar A, Basiri P, Moradi M, Jahangiri A, Naderi K, Ghasemi S, Khatami P, Honari M, Khodaverdloo S, Shooshtari M, Mehr Azin H, Moradi S, Shafaghi B, Allahyari H, Monazah A, Khodaei Poor A, Taghva Z, Bakhshande H, Karimi Nia M, Solaymani Dodaran M, Forooghizade M. Gholami F, et al. Among authors: rahimi z. BMC Infect Dis. 2023 Feb 24;23(1):118. doi: 10.1186/s12879-023-08079-1. BMC Infect Dis. 2023. PMID: 36829111 Free PMC article. Clinical Trial.
Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial.
Ahi M, Hamidi Farahani R, Basiri P, Karimi Rahjerdi A, Sheidaei A, Gohari K, Rahimi Z, Gholami F, Moradi M, Ghafoori Naeeni F, Saffar KN, Ghasemi S, Barati B, Moradi S, Monazah A, Pouranvari F, Forooghizadeh M. Ahi M, et al. Among authors: rahimi z. Vaccines (Basel). 2022 Oct 26;10(11):1800. doi: 10.3390/vaccines10111800. Vaccines (Basel). 2022. PMID: 36366308 Free PMC article.
Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial.
Solaymani-Dodaran M, Basiri P, Moradi M, Gohari K, Sheidaei A, Ahi M, Ghafoori Naeeni F, Ansarifar A, Rahimi Z, Gholami F, Karimi Rahjerdi A, Hamidi Farahani R, Naderi Saffar K, Ghasemi S, Shooshtari A, Honari M, Mozafari A, Khodaverdloo S, Forooghizadeh M. Solaymani-Dodaran M, et al. Among authors: rahimi z. Virol J. 2023 Jul 18;20(1):154. doi: 10.1186/s12985-023-02121-z. Virol J. 2023. PMID: 37464440 Free PMC article. Clinical Trial.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial.
Ansarifar A, Farahani RH, Rahjerdi AK, Ahi M, Sheidaei A, Gohari K, Rahimi Z, Gholami F, Basiri P, Moradi M, Jahangiri A, Naderi K, Ghasemi S, Khatami P, Honari M, Khodaverdloo S, Shooshtari M, Azin HM, Moradi S, Shafaghi B, Allahyari H, Monazah A, Poor AK, Bakhshande H, Taghva Z, Nia MK, Dodaran MS, Foroughizadeh M. Ansarifar A, et al. Among authors: rahimi z. Vaccine X. 2023 Oct 27;15:100401. doi: 10.1016/j.jvacx.2023.100401. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37941802 Free PMC article.
The association between dietary inflammatory index with some cardio-metabolic risk indices among the patients with type 2 diabetes from Hoveyzeh cohort study: a cross-sectional study.
Rahimlou M, Ahmadi AR, Cheraghian B, Baghdadi G, Ghalishourani SS, Nozarian S, Hashemi SJ, Rahimi Z, Jahromi NB, Hosseini SA. Rahimlou M, et al. Among authors: rahimi z. BMC Endocr Disord. 2024 Jun 19;24(1):91. doi: 10.1186/s12902-024-01624-2. BMC Endocr Disord. 2024. PMID: 38890603
Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050.
GBD 2019 MSK in Adolescents Collaborators. Electronic address: dongze_wu@163.com; GBD 2019 MSK in Adolescents Collaborators. GBD 2019 MSK in Adolescents Collaborators. Electronic address: dongze_wu@163.com, et al. Med. 2024 May 30:S2666-6340(24)00179-X. doi: 10.1016/j.medj.2024.04.009. Online ahead of print. Med. 2024. PMID: 38834074 Free article.
263 results